FTC To Block Amgen’s Deal To Acquire Horizon Therapeutics – Source
(Reuters) – The US Federal Trade Commission (FTC) is expected to file a lawsuit as early as Tuesday to block Amgen Inc’s $27.8 billion deal to buy Horizon Therapeutics PLC, a person familiar with the matter told Reuters. Last year, Amgen agreed to buy Horizon to strengthen its rare diseases drugs portfolio and said it…
